We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
CALL
General Dynamics
GD
$103B
| $549K | 0.01% |
4,000
| – | – |
|
|
977
PUT
General Dynamics
GD
$103B
| $549K | 0.01% |
4,000
| – | – |
|
978
Labcorp
LH
$25.2B
| $548K | 0.01% |
5,160
-21,877
| -81% | -$2.26M |
|
|
ESND
979
DELISTED
Essendant Inc.
ESND
| $548K | 0.01% |
16,883
-8,902
| -35% | -$303K |
|
980
Choice Hotels
CHH
$5.26B
| $547K | 0.01% |
+10,837
| New | +$554K |
|
|
VER
981
DELISTED
VEREIT, Inc.
VER
| $546K | 0.01% |
13,780
-721
| -5% | -$29.6K |
|
|
OPB
982
DELISTED
Opus Bank Common Stock
OPB
| $545K | 0.01% |
+14,733
| New | +$554K |
|
983
PUT
Caterpillar
CAT
$361B
| $544K | 0.01% |
8,000
-34,000
| -81% | -$2.38M |
|
984
Power Integrations
POWI
$3.15B
| $544K | 0.01% |
+22,402
| New | +$546K |
|
|
NTUS
985
DELISTED
Natus Medical Inc
NTUS
| $543K | 0.01% |
+11,302
| New | +$523K |
|
986
News Corp Class A
NWSA
$15.6B
| $541K | 0.01% |
40,509
-10,701
| -21% | -$151K |
|
987
CVR Energy
CVI
$3.48B
| $539K | 0.01% |
13,681
+4,979
| +57% | +$215K |
|
|
HRC
988
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $538K | 0.01% |
11,183
-6,354
| -36% | -$324K |
|
989
CALL
Marriott International
MAR
$100B
| $536K | 0.01% |
8,000
| – | – |
|
|
990
PUT
Marriott International
MAR
$100B
| $536K | 0.01% |
8,000
| – | – |
|
|
COHR
991
DELISTED
Coherent Inc
COHR
| $534K | 0.01% |
+8,200
| New | +$505K |
|
992
Nasdaq
NDAQ
$53.4B
| $531K | 0.01% |
+27,381
| New | +$521K |
|
|
WBC
993
DELISTED
WABCO HOLDINGS INC.
WBC
| $530K | 0.01% |
5,182
-1,834
| -26% | -$195K |
|
|
TLMR
994
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $530K | 0.01% |
29,262
+10,286
| +54% | +$178K |
|
995
Mohawk Industries
MHK
$6.91B
| $526K | 0.01% |
2,775
-6,467
| -70% | -$1.24M |
|
|
BRCD
996
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $525K | 0.01% |
57,234
-11,269
| -16% | -$111K |
|
997
COPT Defense Properties
CDP
$4.32B
| $524K | 0.01% |
+24,044
| New | +$534K |
|
998
Regal Rexnord
RRX
$12.5B
| $524K | 0.01% |
8,947
-5,977
| -40% | -$366K |
|
|
NATI
999
DELISTED
National Instruments Corp
NATI
| $524K | 0.01% |
+18,267
| New | +$541K |
|
1000
Adobe
ADBE
$105B
| $523K | 0.01% |
+5,570
| New | +$500K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.